{"id":"https://openalex.org/W2620877413","doi":"https://doi.org/10.2174/1871527316666170602101538","title":"C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease","display_name":"C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease","publication_year":2017,"publication_date":"2017-06-30","ids":{"openalex":"https://openalex.org/W2620877413","doi":"https://doi.org/10.2174/1871527316666170602101538","mag":"2620877413","pmid":"https://pubmed.ncbi.nlm.nih.gov/28571531"},"language":"en","primary_location":{"id":"doi:10.2174/1871527316666170602101538","doi":"https://doi.org/10.2174/1871527316666170602101538","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871527316666170602101538","pdf_url":null,"source":{"id":"https://openalex.org/S148418319","display_name":"CNS & Neurological Disorders - Drug Targets","issn_l":"1568-007X","issn":["1568-007X","1871-5273","1996-3181","2212-5299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS & Neurological Disorders - Drug Targets","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024753707","display_name":"Abdelrahman Ibrahim Abushouk","orcid":"https://orcid.org/0000-0003-1399-6487","observed_orcids":["https://orcid.org/0000-0003-1399-6487"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdelrahman Ibrahim Abushouk","raw_affiliation_strings":["Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019447790","display_name":"Ahmed Negida","orcid":"https://orcid.org/0000-0001-5363-6369","observed_orcids":["https://orcid.org/0000-0001-5363-6369"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ahmed Negida","raw_affiliation_strings":["Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086480418","display_name":"Rasha Abdelsalam Elshenawy","orcid":"https://orcid.org/0000-0002-8954-0817","observed_orcids":["https://orcid.org/0000-0002-8954-0817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rasha Abdelsalam Elshenawy","raw_affiliation_strings":["Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047108905","display_name":"Hossam Zein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hossam Zein","raw_affiliation_strings":["Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048651747","display_name":"Ali Mohamed Hammad","orcid":"https://orcid.org/0000-0002-4217-0353","observed_orcids":["https://orcid.org/0000-0002-4217-0353"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ali M. Hammad","raw_affiliation_strings":["Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081422078","display_name":"Ahmed Menshawy","orcid":"https://orcid.org/0000-0003-2697-7613","observed_orcids":["https://orcid.org/0000-0003-2697-7613"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed Menshawy","raw_affiliation_strings":["Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Group of Egypt, Zagazig, El-Sharkia, Egypt","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048703191","display_name":"Wael M.Y. Mohamed","orcid":"https://orcid.org/0000-0003-1317-0829","observed_orcids":["https://orcid.org/0000-0003-1317-0829"]},"institutions":[{"id":"https://openalex.org/I4164984","display_name":"International Islamic University Malaysia","ror":"https://ror.org/03s9hs139","country_code":"MY","type":"education","lineage":["https://openalex.org/I4164984"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Wael M.Y. Mohamed","raw_affiliation_strings":["Basic Medical Science Department, Faculty of Medicine, International Islamic University Malaysia, Kuantan, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basic Medical Science Department, Faculty of Medicine, International Islamic University Malaysia, Kuantan, Malaysia","institution_ids":["https://openalex.org/I4164984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019447790"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6014,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.88941387,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"17","issue":"1","first_page":"14","last_page":"21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9750000238418579},{"id":"https://openalex.org/keywords/c-abl-kinase","display_name":"c-Abl kinase","score":0.9269999861717224},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9049999713897705},{"id":"https://openalex.org/keywords/dopaminergic-neuron-death","display_name":"dopaminergic neuron death","score":0.8989999890327454},{"id":"https://openalex.org/keywords/alpha-synuclein-aggregation","display_name":"alpha-synuclein aggregation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.9549999833106995},{"id":"https://openalex.org/keywords/lewy-bodies","display_name":"Lewy bodies","score":0.7639999985694885},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.3970000147819519}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.9105509519577026},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.820253849029541},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.7354962229728699},{"id":"https://openalex.org/C2777668072","wikidata":"https://www.wikidata.org/wiki/Q2472777","display_name":"Parkin","level":4,"score":0.6968982815742493},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5958772897720337},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5699793100357056},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5471590161323547},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.46177566051483154},{"id":"https://openalex.org/C2780427247","wikidata":"https://www.wikidata.org/wiki/Q409961","display_name":"LRRK2","level":4,"score":0.43889957666397095},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.43295055627822876},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42925435304641724},{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.41772955656051636},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3516167104244232},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.251623272895813},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.18782943487167358},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14961886405944824},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.144881010055542},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06205889582633972},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000066829","descriptor_name":"Neuroprotection","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000066829","descriptor_name":"Neuroprotection","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D016315","descriptor_name":"Proto-Oncogene Proteins c-abl","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016315","descriptor_name":"Proto-Oncogene Proteins c-abl","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/1871527316666170602101538","doi":"https://doi.org/10.2174/1871527316666170602101538","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871527316666170602101538","pdf_url":null,"source":{"id":"https://openalex.org/S148418319","display_name":"CNS & Neurological Disorders - Drug Targets","issn_l":"1568-007X","issn":["1568-007X","1871-5273","1996-3181","2212-5299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS & Neurological Disorders - Drug Targets","raw_type":"journal-article"},{"id":"pmid:28571531","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28571531","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS & neurological disorders drug targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2540689820","https://openalex.org/W2575392409","https://openalex.org/W3215211915","https://openalex.org/W4409548715","https://openalex.org/W2896422791","https://openalex.org/W2901089527","https://openalex.org/W2003247806","https://openalex.org/W3201955475","https://openalex.org/W4391259872","https://openalex.org/W2034535617"],"abstract_inverted_index":{"Parkinson's":[0],"disease":[1,49],"(PD)":[2],"is":[3,33,117],"the":[4,10,24,30,54,65,85,94,139,148,157,169,177,183,193],"most":[5],"prevalent":[6],"movement":[7,158],"disorder":[8],"in":[9,79,93,119,173,206],"world.":[11],"The":[12],"major":[13],"pathological":[14,67],"hallmarks":[15],"of":[16,20,26,56,62,69,87,96,107,171,179],"PD":[17,153,174],"are":[18,40,43],"death":[19],"dopaminergic":[21,130],"neurons":[22],"and":[23,48,104,121,128,138,154,176,182,196],"formation":[25],"Lewy":[27],"bodies.":[28],"At":[29],"moment,":[31],"there":[32],"no":[34],"cure":[35],"for":[36,45,150,203],"PD;":[37],"current":[38,197],"treatments":[39],"symptomatic.":[41],"Investigators":[42],"searching":[44],"neuroprotective":[46,77,126],"agents":[47],"modifying":[50],"strategies":[51],"to":[52,60,75],"slow":[53],"progress":[55],"neurodegeneration.":[57],"However,":[58],"due":[59],"lack":[61],"data":[63],"about":[64],"main":[66],"sequence":[68],"PD,":[70],"many":[71],"drug":[72],"targets":[73],"failed":[74],"provide":[76,201],"effects":[78,127],"human":[80],"trials.":[81,162],"Recent":[82],"evidence":[83,134],"suggests":[84],"involvement":[86],"C-Abelson":[88],"(c-Abl)":[89],"tyrosine":[90],"kinase":[91],"enzyme":[92],"pathogenesis":[95,175],"PD.":[97],"Through":[98],"parkin":[99],"inactivation,":[100],"alpha":[101],"synuclein":[102],"aggregation,":[103],"impaired":[105],"autophagy":[106],"toxic":[108],"elements.":[109],"Experimental":[110],"studies":[111,137],"showed":[112],"that":[113,144],"(1)":[114],"c-Abl":[115,123,145,172],"activation":[116],"involved":[118],"neurodegeneration":[120],"(2)":[122],"inhibition":[124,146],"shows":[125,143],"prevents":[129],"neuronal'":[131],"death.":[132],"Current":[133],"from":[135,192],"experimental":[136],"first":[140,184],"in-human":[141,185],"trial":[142],"holds":[147],"promise":[149],"neuroprotection":[151],"against":[152],"therefore,":[155],"justifies":[156],"towards":[159],"larger":[160],"clinical":[161],"In":[163,187],"this":[164,207],"review":[165],"article,":[166],"we":[167,200],"discussed":[168],"role":[170],"findings":[178],"preclinical":[180,198],"experiments":[181],"trial.":[186],"addition,":[188],"based":[189],"on":[190],"lessons":[191],"last":[194],"decade":[195],"evidence,":[199],"recommendations":[202],"future":[204],"research":[205],"area.":[208]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-06-09T00:00:00"}